Dr. Sacha Nahon-Estève

Dr. Sacha Nahon-Estève

Ocular oncologist

Dr. Sacha Nahon-Estève is specialized in vitreoretinal surgery and ocular oncology. He manages patients with conjunctival and intraocular tumors, both medically and surgically. His procedures include tumor excision as well as the placement of localization systems prior to proton therapy.

Short Bio

Originally from Marseille, where he completed part of his medical studies, Sacha Nahon-Estève moved to Nice in 2014 to complete his ophthalmology training. After spending several months at the Laboratory of Clinical and Experimental Pathology (LPCE), he turned to ocular oncology, working alongside Dr. Jean-Pierre Caujolle and Dr. Célia Maschi at the Nice University Hospital. Today, he manages patients with ocular surface and intraocular tumors.

In addition to his hospital-based clinical and surgical work, he teaches at Université Côte d’Azur and is involved in both clinical and basic research, working at the LPCE and the Mediterranean Center for Molecular Medicine (C3M).

Career path

  • University Hospital Clinical Lecturer (2020–2023) – Nice University Hospital, Nice, France
  • Hospital Practitioner (2023–present) – Nice University Hospital, Nice, France

Education

  • Interuniversity Diploma (DIU) in Ocular Infections and Inflammations (2016) – Paris Diderot University, Paris, France
  • Interuniversity Diploma (DIU) in Retinal Imaging and Retinal Pathology (2019) – Paris Diderot University, Paris, France
  • Specialized Studies Diploma (DES) in Ophthalmology (2019) – University of Nice Sophia-Antipolis, Nice, France
  • State Diploma of Doctor of Medicine (2019) – University of Nice Sophia-Antipolis, Nice, France
  • Master’s Degree (Master 2) in Health Biology, Oncology Specialization (2020) – Aix-Marseille University, Marseille, France

Publications

Publications: 48
Citations: 370 by 311 publications
h-index: 12
ORCID: https://orcid.org/0000-0003-2274-0256

  • Nhari M, Nahon-Esteve S, Nguyen AM, Kodjikian L, Mathis T. Diagnosis of a uveal melanoma arising from the choroid beneath a congenital hypertrophy of the retinal pigment epithelium: the value of microvascular flow imaging. Can J Ophthalmol. 2024;59(5):e643-e646. doi: 10.1016/j.jcjo.2024.03.006
  • Nahon-Estève S, Orbach D, Le Loarer F, Hofman P, Lassalle S. Fibroblastic orbital tumour with NTRK1 fusion transcript: when TRK inhibitors rescue surgery. Can J Ophthalmol. 2024;59(4):e407-e409. doi: 10.1016/j.jcjo.2023.11.008
  • Proteau S, Krossa I, Husser C, Guéguinou M, Sella F, Bille K, Irondelle M, Dalmasso M, Barouillet T, Cheli Y, Pisibon C, Arrighi N, Nahon-Estève S, Martel A, Gastaud L, Lassalle S, Mignen O, Brest P, Mazure NM, Bost F, Baillif S, Landreville S, Turcotte S, Hasson D, Carcamo S, Vandier C, Bernstein E, Yvan-Charvet L, Levesque MP, Ballotti R, Bertolotto C, Strub T. LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition. EMBO Mol Med. 2023;15(12):e17719. doi: 10.15252/emmm.202317719
  • Nahon-Estève S, Martel A, Maschi C, Baillif S, Lassalle S, Caujolle JP. Swept-Source and Spectral-Domain OCT Imaging of Conjunctival Tumors. Ophthalmology. 2021;128(6):947-950. doi: 10.1016/j.ophtha.2020.09.036
  • Lassalle S, Nahon-Esteve S, Frouin E, Boulagnon-Rombi C, Josselin N, Cassoux N, Barnhill R, Scheller B, Baillif S, Hofman P. PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome. Int J Mol Sci. 2020;21(23):9147. doi: 10.3390/ijms21239147

Publication list